Blood test may cut asthma attacks in half
NCT ID NCT07486401
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a blood test that measures eosinophil levels can help doctors tailor asthma treatments more effectively than standard care. About 240 adults with mild to moderate asthma will be followed for one year. The goal is to see if this approach reduces asthma attacks, improves symptom control, and enhances quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA EXACERBATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Healthcare Group Polyclinics
RECRUITINGSingapore, 308205, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Two-Day steroid course replace five days for severe asthma in kids?
- Centenarians put to the test: can exercise reverse frailty at age 100?
- Centenarians in spain offer clues to living past 100 in good health
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- ER-to-Specialist telehealth boost could cut asthma attacks
- Blood test could detect Alzheimer's years before symptoms worsen